Embecta Corp.
16.0M
$230.96M
8.62
$1.64
No price alerts set. Add an alert to get notified!
8.62
-1.26
$1.64
-14.65%
8.83%
30.48%
Compare TSM with similar companies in the sector
| Company | Price | Change % | P/E | Market Cap | D/E |
|---|---|---|---|---|---|
|
AQST
Aquestive Therapeutics, Inc.
|
$4.18 | -0.95% | -6.08 | $415.10M | -3.90 |
|
CDNA
CareDx, Inc
|
$20.70 | -1.24% | -129.24 | $1.07B | 0.06 |
|
EBS
Emergent BioSolutions Inc.
|
$9.05 | 5.97% | -54.62 | $467.38M | 1.10 |
|
EVH
Evolent Health, Inc.
|
$3.91 | -2.01% | -0.84 | $445.81M | 2.38 |
|
MRVI
Maravai LifeSciences Holdings, Inc.
|
$3.85 | 1.58% | -4.27 | $555.64M | 0.17 |
|
MYGN
Myriad Genetics, Inc.
|
$5.03 | 1.82% | -1.18 | $470.35M | 0.63 |
|
PRME
Prime Medicine, Inc.
|
$3.39 | -2.31% | -2.51 | $612.07M | 0.96 |
|
PSNL
Personalis, Inc.
|
$5.56 | -5.76% | -6.31 | $493.75M | 0.12 |
|
SIGA
SIGA Technologies, Inc.
|
$4.64 | 0.22% | 14.25 | $332.43M | 0.00 |
|
VIR
Vir Biotechnology, Inc.
|
$10.01 | -1.67% | -3.18 | $1.61B | 0.24 |
* Peer stocks are selected based on market capitalization and sector
$15.55
$3.90
$0.60
4.25%
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
